The Pandemic Exposed Global Gaps in Access to Medicines. Can a Contentious Approach to Close Them Gain Traction?

“We're stuck in a rut. Voluntary licensing is only a partial solution to wider access,” Brook Baker, senior policy analyst for Health GAP, tells STAT.